Your session is about to expire
← Back to Search
Soft Robotic Exosuit
Robotic Exosuit Augmented Locomotion (REAL) in the Clinic and Community (REAL-m Trial)
N/A
Waitlist Available
Led By Louis N Awad, PhD, PT
Research Sponsored by Boston University Charles River Campus
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-training evaluation)
Awards & highlights
No Placebo-Only Group
Summary
This trial tests soft robotic exosuits to help stroke patients walk better by supporting their ankles. The goal is to see if these exosuits can improve walking ability through intense training. Researchers will measure how well patients walk and move over time to understand their effectiveness. Soft robotic exosuits have been shown to facilitate immediate increases in walking speeds and improve walking performance in people with post-stroke hemiparesis.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ retention evaluation (up to 4 weeks post-washout)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~retention evaluation (up to 4 weeks post-washout)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
10-Meter Walk Test (10MWT)
6-Minute Walk Test (6MWT)
Forward propulsion
Secondary study objectives
Dynamic Motor Control Index
Fugl-Meyer Assessment - Lower Extremity Subsection
Muscle Synergies
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: REAL TrainingExperimental Treatment1 Intervention
Robotic Exosuit Augmented Locomotion (REAL) refers to gait training with soft robotic exosuits, performed under a speed-based approach where participants are asked to walk at faster speeds in treadmill and overground environments. Cues and summary feedback emphasizing walking speed and forward propulsion are provided by the physical therapist to facilitate goal-directed walking practice. Training is progressively challenging based on environmental complexity and practice variability. REAL includes 12 training sessions, administered 2-3x/week. Each session includes 30 minutes of total walking time.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Soft Exosuit
2022
N/A
~30
Find a Location
Who is running the clinical trial?
Spaulding Rehabilitation HospitalOTHER
139 Previous Clinical Trials
11,075 Total Patients Enrolled
25 Trials studying Stroke
936 Patients Enrolled for Stroke
Harvard UniversityOTHER
233 Previous Clinical Trials
473,905 Total Patients Enrolled
4 Trials studying Stroke
79 Patients Enrolled for Stroke
Boston University Charles River CampusLead Sponsor
121 Previous Clinical Trials
13,423 Total Patients Enrolled
3 Trials studying Stroke
65 Patients Enrolled for Stroke
Louis N Awad, PhD, PTPrincipal InvestigatorBoston University